tab baricitinib 4 mg daily
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Overview
tab baricitinib 4 mg daily is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
tab baricitinib 4 mg daily clinical trials
Explore related
Medical disclaimer. This page summarizes research about tab baricitinib 4 mg daily for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.